CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 2,366 shares at an average $92.25 ($218,253)
- 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $91.49 ($457,434)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $92.45 ($1,386,794)
- 4 Planned sale CHIEF OPERATING OFFICER sold 8,000 shares at an average $92.49 ($739,885)
- 4 Planned sale PRESIDENT AND CFO sold 8,000 shares at an average $85.81 ($686,518)
- 4 Gift CHIEF EXECUTIVE OFFICER gave 710 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 2,366 shares at an average $103.89 ($245,796)
- 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $106.36 ($531,803)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $106.82 ($1,602,252)
- 4 Planned sale CHIEF OPERATING OFFICER sold 8,000 shares at an average $106.80 ($854,423)
- 4 Option exercise CHIEF OPERATING OFFICER acquired 5,049 shares (option exercise)
- 4 Option exercise PRESIDENT AND CFO acquired 19,108 shares (option exercise)
- 4 Planned sale PRESIDENT AND CFO sold 42,000 shares at an average $115.39 ($4,846,508)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 7,098 shares at an average $109.21 ($775,154)
- 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $109.27 ($546,353)
Page 6 of 22 · 421 filings